Cargando…
A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413295/ https://www.ncbi.nlm.nih.gov/pubmed/34475375 http://dx.doi.org/10.1038/s41392-021-00666-5 |
| _version_ | 1783747631042789376 |
|---|---|
| author | Fan, Jiansheng Zhuang, Xinlei Yang, Xiaoyue Xu, Yingchun Zhou, Zhan Pan, Liqiang Chen, Shuqing |
| author_facet | Fan, Jiansheng Zhuang, Xinlei Yang, Xiaoyue Xu, Yingchun Zhou, Zhan Pan, Liqiang Chen, Shuqing |
| author_sort | Fan, Jiansheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8413295 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84132952021-09-22 A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models Fan, Jiansheng Zhuang, Xinlei Yang, Xiaoyue Xu, Yingchun Zhou, Zhan Pan, Liqiang Chen, Shuqing Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-09-03 /pmc/articles/PMC8413295/ /pubmed/34475375 http://dx.doi.org/10.1038/s41392-021-00666-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Fan, Jiansheng Zhuang, Xinlei Yang, Xiaoyue Xu, Yingchun Zhou, Zhan Pan, Liqiang Chen, Shuqing A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models |
| title | A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models |
| title_full | A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models |
| title_fullStr | A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models |
| title_full_unstemmed | A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models |
| title_short | A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models |
| title_sort | multivalent biparatopic egfr-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413295/ https://www.ncbi.nlm.nih.gov/pubmed/34475375 http://dx.doi.org/10.1038/s41392-021-00666-5 |
| work_keys_str_mv | AT fanjiansheng amultivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT zhuangxinlei amultivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT yangxiaoyue amultivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT xuyingchun amultivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT zhouzhan amultivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT panliqiang amultivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT chenshuqing amultivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT fanjiansheng multivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT zhuangxinlei multivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT yangxiaoyue multivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT xuyingchun multivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT zhouzhan multivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT panliqiang multivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels AT chenshuqing multivalentbiparatopicegfrtargetingnanobodydrugconjugatedisplayspotentanticanceractivityinsolidtumormodels |